Biomarkers Market to Exceed US$ 60.0 Exceed by 2023
The Biomarkers market is expected to exceed more than US$ 60.0 billion by 2023 growing at around 13% CAGR.
Browse Full Report: https://www.marketresearchengine.com/reportdetails/biomarkers-market
Biomarkers are biological measures used to measure biological states such as blood pressure, cholesterol level and monitor and forecast health level of individual. Biomarkers are used in single or in combination to identify health or disease of individual. Different varieties of biomarkers are used currently for various applications. Every biological system consists of its own biomarkers. Some biomarkers are easy to use, measure and form part of routine medical examinations. Biomarkers are used to estimate health and disease of individual such as diabetes and cardiovascular. Biomarkers are used for detection, screening, diagnosis, treatment and monitoring of cancer.
The main driving factors for biomarkers market are increase in number of low cost for conducting clinical trials in developing countries. Rising healthcare expenditure and R&D funding are the major macro drivers of the market. The use of biomarkers in diagnostic process is increasing rapidly due to its more accurate results. The biomarkers also have some restraints such as it contain technical issues related to sample and storage. The testing cost of biomarkers is high. It contains high investment but relatively low cost and benefit ratio.
Download Free Sample Report: https://www.marketresearchengine.com/requestsample/biomarkers-market
This report provides:
1) An overview of the global market for biomarkers and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2023.
3) Identifications of new market opportunities and targeted promotional plans for biomarkers.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The scope of the report includes a detailed study of global and regional markets for various types of biomarkers with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include QIAGEN N.V. (Netherlands), PerkinElmer, Inc., Merck & Co, Inc., Bio-Rad Laboratories , Enzo Biochem , EKF Diagnostics Holdings plc , Meso Scale Diagnostics, LLC , Singulex, Inc. , BioSims Technologies , Cisbio Bioassays , and Signosis, Inc.. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Biomarkers Market has been segmented as below:
By Product Segment Analysis
By Type Analysis
• Safety biomarker,
• Efficacy biomarker
• Validation biomarker
By Application Analysis
• Diagnostics development
• Drug discovery & development
• Personalized medicine
• Disease risk assessment
By Disease Indication Analysis
• Cardiovascular disorders
• Neurological disorders
• Immunological disorders
By Regional Analysis
• North America
• Rest of the World
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Company Name: Market Research Engine
Contact Person: John Bay
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biomarkers Market to Exceed US$ 60.0 Exceed by 2023 here
News-ID: 438845 • Views: 333
More Releases from MRE Study
Aerogels Market Size will Exceed US$ 1100 Million By 2023
It is estimated that globally the aerogels market will rise at CAGR of a value greater than 18% during the period 2015-2023. In the year 2015, the value of the aerogels market stands at US $353.6 million. It is expected to reach a valuation of about US $1100.2 million by the end of 2023. The popularity of aerogel as an industrial item is because of its attributes (light weight, low
Global Antibacterial Drugs Market Cap will Increase more than US$ 38 Billion by …
Antibiotic is a term used for referring antimicrobial which is produced by molds and bacteria. Drugs prepared using antimicrobial are known as antibacterial drugs which acts on the body in different ways, such as it enhances the permeability of cell membrane and restrict the metabolism, nuclei and protein synthesis. These antibacterial drugs are highly effective in preventing and curing various types of bacterial infection. It acts on the harmful bacteria
Smart Elevators and Escalators Market is Expected to Exceed US$ 150 Billion by 2 …
The smart elevators and escalators market is segmented on the lines of its type, application and regional. Based on type segmentation the smart elevators and escalators market covers escalators and elevators. The escalator is further segmented into moving stairs and moving walkway escalators. Based on elevators segmentation it covers 450-1150 kg, 1150-1500 kg and 1500-2000 kg. The smart elevators and escalators market is segmented on the lines of its application
Smart Airports Market is Expected to Cross US$ 19 Billion Globally by 2024
The smart airports market is segmented on the lines of its infrastructure, solutions, applications, services and regional. Based on infrastructure segmentation it covers security systems, air/ ground traffic control, passenger, cargo and baggage ground handling control, communication system, endpoint devices and others. Security system is further segmented into biometrics, alerts &cyber security, E-Fence &ground surveillance radar and E-Tag system. Air/ Ground traffic control consists smart systems &scalable air traffic management
More Releases for Biomarkers
Biomarkers Market Fragmented by 2025
Global Biomarkers Market: Snapshot The global biomarkers market is witnessing a tremendous rise in its valuation, thanks to the increase in diagnostic applications of biomarkers. The augmenting investments for research and development activities in the pharma and biotech companies, rising number of CROs, and the low cost associated with the clinical trials in emerging economies are also boosting this market. Going forward, the high prevalence rate of cancer and novel initiatives for
Cancer Biomarkers Market: Regional Overview
Cancer is the second-leading cause of death worldwide (World Health Organization). There were around 14 million new cases of cancer reported across the globe in 2012 and the incidence rate is expected to increase by around 70% by 2030 (WHO). The most common cancer types are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer. Cancer therapies are expensive and the cost rises with increase in complexity or stage
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Biomarkers Market : Analysis & Trends 2023
Global Biomarkers Market A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions
Global Vocal Biomarkers Market
The Global Vocal Biomarkers Market is estimated to be valued at US$ 6.4 million by 2017 and is projected to expand at an astounding CAGR of 65.7% from 2017 to 2028, as analyzed by Coherent Market Insights. Vocal biomarkers enabling early diagnosis and being a non-invasive procedure are analyzed to be major factor fueling uptake of this disruptive technology over the forecast period (2017–2028). Mental and physical conditions such as anxiety
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out